| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |